# FDA recall D-0237-2023

> **Pharmacy Innovations** · Class II · drug recall initiated 2022-12-22.

## Product

TACROLIMUS  0.03% OPH SOLUTION TACROLIMUS  0.1% (1ML DROPTAINER) OPH SOLUTION TACROLIMUS -CORN OIL- 0.03% OPH SOLUTION TACROLIMUS-VET- 0.02% (10ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.02% (15ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.02% (5ML DROPPER) OPHTHALMIC TACROLIMUS-VET- 0.03% (10ML DROPPER) OPHTHALMIC, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

## Reason for recall

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0237-2023
- **Recalling firm:** Pharmacy Innovations
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-22
- **Report date:** 2023-02-01
- **Termination date:** 2024-07-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Erie, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0237-2023

## Citation

> AI Analytics. FDA recall D-0237-2023. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0237-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*